Citations (55)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Blessing N. Marandure, Samson Mhizha & Amanda Wilson. (2023) “Spice Was Made, by the Devil Himself”: A Thematic Analysis of the Experience of an Addiction to Synthetic Cannabinoids. Journal of Psychoactive Drugs 55:3, pages 321-329.
Read now
Read now
Benjamin Crulli, Alison M. Dines, Georgina Blanco, Isabelle Giraudon, Florian Eyer, Matthias E. Liechti, Òscar Miró, Knut E. Hovda, Fridtjof Heyerdahl, Christopher Yates, Odd Martin Vallersnes, David M. Wood, Paul I. Dargan, Lukasz Anand, Kurt Anseeuw, Robertas Badaras, Jeffrey Bonnici, Miran Brvar, Blazena Caganova, Feriyde Calýskan, Alessandro Ceschi, Karam Chamoun, Laurence Daveloose, Miguel Galicia, Stefanie Geith, Ketevan Gorozia, Damjan Grenc, Femke Gresnigt, Laura Hondebrink, Gesche Jürgens, Jutta Konstari, Soso Kutubidze, Gabija Laubner, Evangelia Liakoni, Viesturs Liguts, Cathelijne Lyphout, Thomas MacMahon, Bruno Mégarbane, Adrian Moughty, Gabriela Viorela Nitescu, Roberta Noseda, Niall O'Connor, Raido Paasma, Juan Ortega Perez, Marius Perminas, Per Sverre Persett, Kristiina Põld, Jordi Puiguriguer, Julia Radenkova-Saeva, Jan Rulisek, Yasmin Schmid, Irene Scholz, Roberts Stašinskis, Jonas Surkus, Wesley van den Busken, Irma van den Hengel-Koot, Federico Vigorita, Wojciech Waldmanm, William Stephen Waring & Sergej Zacharov. (2022) Novel psychoactive substances-related presentations to the emergency departments of the European drug emergencies network plus (Euro-DEN plus) over the six-year period 2014–2019. Clinical Toxicology 60:12, pages 1318-1327.
Read now
Read now
Ruben Goncalves, Magali Labadie, Simon Chouraqui, Alexandre Peyré, Nadège Castaing, Amélie Daveluy & Mathieu Molimard. (2022) Involuntary MDMB-4en-PINACA intoxications following cannabis consumption: clinical and analytical findings. Clinical Toxicology 60:4, pages 458-463.
Read now
Read now
Erdogan Yasar, Hatice Suhan Tomac & Ugur Gurlevik. (2022) A Case of Presumed Bonsai-induced Severe Toxic Optic Neuropathy. Neuro-Ophthalmology 46:1, pages 41-43.
Read now
Read now
Articles from other publishers (51)
Brian Patrick Murray & Emily Anne Kiernan. (2024) Physiologic Effects of Substance Use. Emergency Medicine Clinics of North America 42:1, pages 69-91.
Crossref
Crossref
Andrew M. Brandon, Steven R. Baginski, Caroline Peet, Pat Dugard, Henrik Green, Oliver B. Sutcliffe, Niamh Nic Daéid, Lorna A. Nisbet, Kevin D. Read & Craig McKenzie. (2023)
Log D
7.4
and plasma protein binding of synthetic cannabinoid receptor agonists and a comparison of experimental and predicted lipophilicity
. Drug Testing and Analysis.
Crossref
Crossref
Caitlyn Norman, Kristin Webling, Oleksandra Kyslychenko, Robert Reid, Alex J. Krotulski, Ryan Farrell, Marie H. Deventer, Huiling Liu, Matthew J. Connolly, Claude Guillou, Inge M. J. Vinckier, Barry K. Logan, Niamh NicDaéid, Craig McKenzie, Christophe P. Stove & Henrik Gréen. (2023) Detection in seized samples, analytical characterization, and in vitro metabolism of the newly emerged 5‐bromo‐indazole‐3‐carboxamide synthetic cannabinoid receptor agonists. Drug Testing and Analysis.
Crossref
Crossref
Arpita Roy, Aaryan Gupta & Devvret Verma. (2023) Evaluation of different phytochemicals from Cannabis sativa against Myelin oligodendrocyte glycoprotein receptor. Vegetos.
Crossref
Crossref
Lilli Stephenson, Corinna Van Den Heuvel & Roger W. Byard. (2023) Socioeconomic and psychosocial determinants of substance misuse – a national perspective. Forensic Science, Medicine and Pathology.
Crossref
Crossref
Sergi Ferré, Attila Köfalvi, Francisco Ciruela, Zuzana Justinova & Marco Pistis. (2023) Targeting corticostriatal transmission for the treatment of cannabinoid use disorder. Trends in Pharmacological Sciences 44:8, pages 495-506.
Crossref
Crossref
Caitlyn Norman, Marie H. Deventer, Olivia Dremann, Robert Reid, Katleen Van Uytfanghe, Claude Guillou, Inge M. J. Vinckier, Niamh Nic Daéid, Alex Krotulski & Christophe P. Stove. (2023) In vitro cannabinoid receptor activity, metabolism, and detection in seized samples of CH‐PIATA, a new indole‐3‐acetamide synthetic cannabinoid. Drug Testing and Analysis.
Crossref
Crossref
Szabolcs Dvorácskó, Tímea Körmöczi, Éva Sija, Balázs Bende, Roland Weiczner, Tibor Varga, István Ilisz, László Institóris, Éva M. Kereszty, Csaba Tömböly & Róbert Berkecz. (2023) Focusing on the 5F-MDMB-PICA, 4F-MDMB-BICA synthetic cannabinoids and their primary metabolites in analytical and pharmacological aspects. Toxicology and Applied Pharmacology 470, pages 116548.
Crossref
Crossref
Svetlana SKOBEEVA & John G. FLETCHER. (2023) Synthetic cannabinoid receptor agonists (Spice): the problem they represent and a chemometric solution. Minerva Forensic Medicine 143:1.
Crossref
Crossref
Jiahong Xiang, Di Wen, Junbo Zhao, Ping Xiang, Yan Shi & Chunling Ma. (2023) Study of the Metabolic Profiles of “Indazole-3-Carboxamide” and “Isatin Acyl Hydrazone” (OXIZID) Synthetic Cannabinoids in a Human Liver Microsome Model Using UHPLC-QE Orbitrap MS. Metabolites 13:4, pages 576.
Crossref
Crossref
Chinaza Godswill Awuchi, Maduabuchi Patrick Aja, Nancy Bonareri Mitaki, Sonia Morya, Ikechukwu O. Amagwula, Chinelo Kate Echeta & Victory S. Igwe. (2023) New Psychoactive Substances: Major Groups, Laboratory Testing Challenges, Public Health Concerns, and Community-Based Solutions. Journal of Chemistry 2023, pages 1-36.
Crossref
Crossref
Liesl K. Janssens, Adam Ametovski, Eric Sparkes, Rochelle Boyd, Felcia Lai, Callan J. Maloney, Dane Rhook, Roy R. Gerona, Matthew Connolly, Huiling Liu, David E. Hibbs, Elizabeth A. Cairns, Samuel D. Banister & Christophe P. Stove. (2022) Comprehensive Characterization of a Systematic Library of Alkyl and Alicyclic Synthetic Cannabinoids Related to CUMYL-PICA, CUMYL-BUTICA, CUMYL-CBMICA, and CUMYL-PINACA. ACS Chemical Neuroscience 14:1, pages 35-52.
Crossref
Crossref
Rachael C. AndrewsBenedict MayFederico J. Hernández, Gyles E. CozierPiers A. Townsend, Oliver B. Sutcliffe, Tom S. F. HainesTom P. FreemanJennifer ScottStephen M. Husbands, Ian S. Blagbrough, Richard W. Bowman, Simon E. Lewis, Matthew N. Grayson, Rachel Crespo-Otero, David R. CarberyChristopher R. Pudney. (2023) Photochemical Fingerprinting Is a Sensitive Probe for the Detection of Synthetic Cannabinoid Receptor Agonists; toward Robust Point-of-Care Detection. Analytical Chemistry.
Crossref
Crossref
Ziteng Wang, Eric Yu Quan Leow, Hooi Yan Moy & Eric Chun Yong Chan. 2023.
Morgan Alonzo & Shanlin Fu. 2023. Encyclopedia of Forensic Sciences, Third Edition. Encyclopedia of Forensic Sciences, Third Edition
660
681
.
Richard C. Kevin, Elizabeth A. Cairns, Rochelle Boyd, Jonathon C. Arnold, Michael T. Bowen, Iain S. McGregor & Samuel D. Banister. (2022) Off-target pharmacological profiling of synthetic cannabinoid receptor agonists including AMB-FUBINACA, CUMYL-PINACA, PB-22, and XLR-11. Frontiers in Psychiatry 13.
Crossref
Crossref
Julie A. Marusich, Thomas F. Gamage, Yanan Zhang, Luli R. Akinfiresoye & Jenny L. Wiley. (2022) In vitro and in vivo pharmacology of nine novel synthetic cannabinoid receptor agonists. Pharmacology Biochemistry and Behavior 220, pages 173467.
Crossref
Crossref
Ali Haider Jafry, Austin LaGrow, Khawaja Hassan Akhtar, Ethan Hacker, Sage Russell, Brian Kliewer & Zain ul Abideen Asad. (2022) Synthetic cannabinoids and ST elevation myocardial infarction. The American Journal of the Medical Sciences 364:4, pages 481-491.
Crossref
Crossref
Amanda L A Mohr, Barry K Logan, Melissa F Fogarty, Alex J Krotulski, Donna M Papsun, Sherri L Kacinko, Marilyn A Huestis & Jeri D Ropero-Miller. (2022) Reports of Adverse Events Associated with Use of Novel Psychoactive Substances, 2017–2020: A Review. Journal of Analytical Toxicology 46:6, pages e116-e185.
Crossref
Crossref
Xiaolin Fan, Jianhe Zhang, Xiaofang Fu, Bo Zhou, Zeqiong Xu, Hongmei Huang, Sheng Han & Xiqing Li. (2022) Analysis of synthetic cannabinoids in wastewater of major cities in China. Science of The Total Environment 827, pages 154267.
Crossref
Crossref
Shana M. Augustin & David M. Lovinger. (2022) Synaptic changes induced by cannabinoid drugs and cannabis use disorder. Neurobiology of Disease 167, pages 105670.
Crossref
Crossref
Alina Bărbulescu, Lucica Barbeș & Cristian Ștefan Dumitriu. (2022) Computer-Aided Methods for Molecular Classification. Mathematics 10:9, pages 1543.
Crossref
Crossref
Ana Bagues, Yolanda López-Tofiño, Álvaro Llorente-Berzal & Raquel Abalo. (2022) Cannabinoid drugs against chemotherapy-induced adverse effects: focus on nausea/vomiting, peripheral neuropathy and chemofog in animal models. Behavioural Pharmacology 33:2&3, pages 105-129.
Crossref
Crossref
Beatriz Correia, Joana Fernandes, Maria João Botica, Carla Ferreira & Alexandre Quintas. (2022) Novel Psychoactive Substances: The Razor’s Edge between Therapeutical Potential and Psychoactive Recreational Misuse. Medicines 9:3, pages 19.
Crossref
Crossref
Tímea Körmöczi, Éva Sija, László Institóris, Éva M Kereszty, István Ilisz & Róbert Berkecz. (2022) Analytical Methodologies for the Characterization and Analysis of the Parent Compound and Phase I Metabolites of 4F-MDMB-BICA in Human Microsome, Urine and Blood Samples. Journal of Analytical Toxicology 46:2, pages 135-145.
Crossref
Crossref
Simone Milan, Filomena Lelario, Laura Scrano, Chiara Ottati, Sabino Aurelio Bufo & Maria de Fátima Alpendurada. (2022) Detection of Eight Cannabinoids and One Tracer in Wastewater and River Water by SPE-UPLC–ESI-MS/MS. Water 14:4, pages 588.
Crossref
Crossref
Cui‐Mei Liu, Zhen‐Dong Hua, Wei Jia & Tao Li. (2021) Identification of AD‐18, 5F‐MDA‐19, and pentyl MDA‐19 in seized materials after the class‐wide ban of synthetic cannabinoids in China. Drug Testing and Analysis 14:2, pages 307-316.
Crossref
Crossref
G. Jean Harry. 2022. Neurotoxicity of Drugs of Abuse. Neurotoxicity of Drugs of Abuse
1
48
.
A.-L. Pélissier-Alicot. 2022. Cannabis and the Developing Brain. Cannabis and the Developing Brain
243
258
.
Harry Sumnall & Amanda Atkinson. 2022. Novel Psychoactive Substances. Novel Psychoactive Substances
85
108
.
Andreas BüttnerAndreas Büttner. 2022. Neuropathologie des Drogenmissbrauchs. Neuropathologie des Drogenmissbrauchs
23
90
.
Beau Carubia & Anne Penner. 2022. Cannabis in Psychiatric Practice. Cannabis in Psychiatric Practice
81
90
.
Alina Bărbulescu, Lucica Barbeș & Cristian-Ştefan Dumitriu. (2021) Computer-Aided Classification of New Psychoactive Substances. Journal of Chemistry 2021, pages 1-11.
Crossref
Crossref
David M. Taylor, Thomas R. E. Barnes & Allan H. Young. 2021. The Maudsley Prescribing Guidelines in Psychiatry. The Maudsley Prescribing Guidelines in Psychiatry
451
536
.
Melissa A. Jackson, Amanda L. Brown, Jennifer Johnston, Richard Clancy, Iain McGregor, Raimondo Bruno, Nick Lintzeris, Mark Montebello, Jennifer Luksza, Jenny Bowman, Nghi Phung, Dave Allsop & Adrian J. Dunlop. (2021) The use and effects of synthetic cannabinoid receptor agonists by New South Wales cannabis treatment clients. Journal of Cannabis Research 3:1.
Crossref
Crossref
Nicolas Gilbert, Andrew Costello, Jamie R. Ellison, Umer Khan, Mark Knight, Michael J. Linnell, Robert Ralphs, Ryan E. Mewis & Oliver B. Sutcliffe. (2021) Synthesis, characterisation, detection and quantification of a novel hexyl-substituted synthetic cannabinoid receptor agonist: (S)-N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-hexyl-1H-indazole-3-carboxamide (ADB-HINACA). Forensic Chemistry 26, pages 100354.
Crossref
Crossref
Jiahua Ji, Jifen Wang & Ying Zhang. (2021) Rapid screening of 23 synthetic cannabinoids in blood by direct analysis in real time - Tandem mass spectrometry. International Journal of Mass Spectrometry 469, pages 116667.
Crossref
Crossref
Andrea Valeri & Emanuela Mazzon. (2021) Cannabinoids and Neurogenesis: The Promised Solution for Neurodegeneration?. Molecules 26:20, pages 6313.
Crossref
Crossref
Astrid Coronado-Álvarez, Karen Romero-Cordero, Lorena Macías-Triana, Agnes Tatum-Kuri, Alba Vera-Barrón, Henning Budde, Sérgio Machado, Tetsuya Yamamoto, Claudio Imperatori & Eric Murillo-Rodríguez. (2021) The synthetic CB1 cannabinoid receptor selective agonists: Putative medical uses and their legalization. Progress in Neuro-Psychopharmacology and Biological Psychiatry 110, pages 110301.
Crossref
Crossref
Ferenc Zádor, Sâmia Joca, Gábor Nagy-Grócz, Szabolcs Dvorácskó, Edina Szűcs, Csaba Tömböly, Sándor Benyhe & László Vécsei. (2021) Pro-Inflammatory Cytokines: Potential Links between the Endocannabinoid System and the Kynurenine Pathway in Depression. International Journal of Molecular Sciences 22:11, pages 5903.
Crossref
Crossref
Keith Norman, Austin L. Ciesielski & Jarrad R. Wagner. (2020) Identification and associated hazards of clandestine drug laboratories. WIREs Forensic Science 3:3.
Crossref
Crossref
Andrew M. Brandon, Lysbeth H. Antonides, Jennifer Riley, Ola Epemolu, Denise A. McKeown, Kevin D. Read & Craig McKenzie. (2021) A Systematic Study of the In Vitro Pharmacokinetics and Estimated Human In Vivo Clearance of Indole and Indazole-3-Carboxamide Synthetic Cannabinoid Receptor Agonists Detected on the Illicit Drug Market. Molecules 26:5, pages 1396.
Crossref
Crossref
Michael T.M. Wang & Helen V. Danesh-Meyer. (2021) Cannabinoids and the eye. Survey of Ophthalmology 66:2, pages 327-345.
Crossref
Crossref
Eef L. Theunissen, Johannes T. Reckweg, Nadia R.P.W. Hutten, Kim P.C. Kuypers, Stefan W. Toennes, Merja A. Neukamm, Sebastian Halter & Johannes G. Ramaekers. (2021) Intoxication by a synthetic cannabinoid (JWH-018) causes cognitive and psychomotor impairment in recreational cannabis users. Pharmacology Biochemistry and Behavior 202, pages 173118.
Crossref
Crossref
Lysbeth H. Antonides, Annelies Cannaert, Caitlyn Norman, Niamh NicDáeid, Oliver B. Sutcliffe, Christophe P. Stove & Craig McKenzie. (2020)
Shape matters: The application of activity‐based
in vitro
bioassays and chiral profiling to the pharmacological evaluation of synthetic cannabinoid receptor agonists in drug‐infused papers seized in prisons
. Drug Testing and Analysis 13:3, pages 628-643.
Crossref
Crossref
Monica Patel, David B. Finlay & Michelle Glass. (2021) Biased agonism at the cannabinoid receptors – Evidence from synthetic cannabinoid receptor agonists. Cellular Signalling 78, pages 109865.
Crossref
Crossref
K.P.C. Kuypers, F.S. Bersani, R. Bruno, B.K. Vicknasingam, A. Roman-Urrestarazu & O. Corazza. (2021) Introducing the new open access Journal Emerging Trends in Drugs, Addiction, and Health. Emerging Trends in Drugs, Addictions, and Health 1, pages 100001.
Crossref
Crossref
Andreas BüttnerAndreas Büttner. 2021. Neuropathology of Drug Abuse. Neuropathology of Drug Abuse
23
87
.
Kenneth B. Walsh & Haley K. Andersen. (2020) Molecular Pharmacology of Synthetic Cannabinoids: Delineating CB1 Receptor-Mediated Cell Signaling. International Journal of Molecular Sciences 21:17, pages 6115.
Crossref
Crossref
Bogdan Ionel Tamba, Gabriela Dumitrita Stanciu, Cristina Mariana Urîtu, Elena Rezus, Raluca Stefanescu, Cosmin Teodor Mihai, Andrei Luca, Gabriela Rusu-Zota, Maria-Magdalena Leon-Constantin, Elena Cojocaru, Bogdan Gafton & Teodora Alexa-Stratulat. (2020) Challenges and Opportunities in Preclinical Research of Synthetic Cannabinoids for Pain Therapy. Medicina 56:1, pages 24.
Crossref
Crossref
Abu Shafi, Alex J. Berry, Harry Sumnall, David M. Wood & Derek K. Tracy. (2020) New psychoactive substances: a review and updates. Therapeutic Advances in Psychopharmacology 10, pages 204512532096719.
Crossref
Crossref